IN-HOSPITAL OR OUT-OF-HOSPITAL INITIATION OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN IN PATIENTS WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION AFTER A WORSENING HEART FAILURE EVENT: THE PARAGLIDE-HF TRIAL.

MLA

Nouhravesh, Nina, et al. “In-Hospital or Out-Of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction After a Worsening Heart Failure Event: The Paraglide-Hf Trial.” Journal of the American College of Cardiology (JACC), vol. 83, no. 13, Apr. 2024, p. 377. EBSCOhost, https://doi.org/10.1016/S0735-1097(24)02367-2.

APA

Nouhravesh, N., Erickson, T., Cyr, D. D., Hernandez, A. F., Morrow, D. A., Velazquez, E. J., Ward, J., Williamson, K., Starling, R. C., Zieroth, S. R., Solomon, S. D., Braunwald, E., & Mentz, R. J. (2024). In-Hospital or Out-Of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction After a Worsening Heart Failure Event: The Paraglide-Hf Trial. Journal of the American College of Cardiology (JACC), 83(13), 377. https://doi.org/10.1016/S0735-1097(24)02367-2

Chicago

Nouhravesh, Nina, Tyler Erickson, Derek D. Cyr, Adrian F. Hernandez, David A. Morrow, Eric J. Velazquez, Jonathan Ward, et al. 2024. “In-Hospital or Out-Of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients with Mildly Reduced or Preserved Ejection Fraction After a Worsening Heart Failure Event: The Paraglide-Hf Trial.” Journal of the American College of Cardiology (JACC) 83 (13): 377. doi:10.1016/S0735-1097(24)02367-2.